Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMX3501: Hydromorphone/Naloxone Ratio Finding in Constipated Pain Patients
NCT00992576Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Jan 2010
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
A Phase 3 trial of naloxone in opioid-induced constipation (OIC), sponsored by Mundipharma. Started Jan 2010; status: completed.
02
Drugs
naloxone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00992576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992576.